Targeted Delivery of STING Agonist via Albumin Nanoreactor Boosts Immunotherapeutic Efficacy against Aggressive Cancers

• Egile Nagusiak: Zhijun Miao (Egilea), Xue Song (Egilea), Anan Xu (Egilea), Chang Yao (Egilea), Peng Li (Egilea), Yanan Li (Egilea), Tao Yang (Egilea), Gang Shen (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<b>Background:</b> Activating the cytosolic innate immune sensor, the cGAS-STING pathway, holds great promise for enhancing antitumor immunity, particularly in combination with immune checkpoint inhibitors (ICIs). However, the clinical application of STING agonists is often hindered by p...